SCHEMBL25112072

SCHEMBL25112072

NNc1cc(C(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 4/20 0.35
GPR35 Q9HC97 1/20 0.34
IDO1 P14902 4/20 0.34
TDO2 P48775 1/20 0.34
MAPT P10636 2/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CES2 O00748 1/20 0.32
PNMT P11086 1/20 0.32
XPO1 O14980 1/20 0.32
ACP1 P24666 1/20 0.31
PTPN7 P35236 1/20 0.31
PTPN12 Q05209 1/20 0.31
PTPN13 Q12923 1/20 0.31
SSU72 Q9NP77 1/20 0.31
P2RX1 P51575 1/20 0.31
CACNA1F O60840 1/20 0.31
CACNA1D Q01668 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL998165 0.81 IDO1 (0.46) GPR35IDO1MAPTRAPGEF4ALDH1A1
Hydrochloric Acid SCHEMBL999258 0.79 IDO1 (0.48) GPR35IDO1MAPTRAPGEF4ALDH1A1
SCHEMBL5778880 0.79 CES2 (0.48) TACR1IDO1TDO2MAPTRAPGEF4
SCHEMBL25113016 0.78 ALDH1A1 (0.35) TACR1IDO1MAPTRAPGEF4ALDH1A1
SCHEMBL997922 0.74 HDAC3 (0.42) GPR35IDO1MAPTRAPGEF4ALDH1A1
SCHEMBL4374429 0.72 RAPGEF4 (0.53) GPR35IDO1MAPTRAPGEF4ALDH1A1
SCHEMBL11677821 0.72 RAPGEF4 (0.52) GPR35IDO1MAPTRAPGEF4ALDH1A1
SCHEMBL25112073 0.72 MAPT (0.43) TACR1GPR35IDO1MAPTRAPGEF4
SCHEMBL27303633 0.72 MAPT (0.34) IDO1MAPTRAPGEF4ALDH1A1MEN1
SCHEMBL2183595 0.71 CES2 (0.37) TACR1IDO1TDO2CES2PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023036217-A1 ACRYLAMIDE COMPOUND AND USE THEREOF 南京明德新药研发有限公司 2023-03-16 WO disclosed